View this email in your browser
Share Share
Tweet Tweet
Forward Forward

Update for Primary Care

Our latest primary care news and guidance.
March 2021
COVID-19News | Clinical knowledge summaries | Into practice | Events | Get involved


New single guideline for managing COVID-19 in children and adults

Our new guideline brings together existing recommendations on managing COVID-19 in children, young people and adults in all care settings. It includes new recommendations on therapeutics and replaces our COVID-19 rapid guidelines on:

  • critical care in adults
  • managing symptoms (including at the end of life) in the community
  • managing suspected or confirmed pneumonia in adults in the community
  • acute myocardial injury
  • antibiotics for pneumonia in adults in hospital
  • acute kidney injury in hospital
  • reducing the risk of venous thromboembolism in over 16s with COVID-19.
View all our COVID-19 guidance


GP and child having a chat with Covid masks on
The Zolgensma drug ampules and box

Children and young people need accurate, accessible information about their healthcare

Our new draft guideline recommends ensuring children and young people are fully informed about their health, so that they are empowered to take an active role in their care. It emphasises the need to provide children and young people with clear and accurate information that can be tailored to each individual patient’s level of maturity and understanding.

Life-changing gene therapy for treating spinal muscular atrophy approved

A new and potentially curative one-off gene therapy for babies with the rare genetic disorder spinal muscular atrophy (SMA) is set to become the most expensive treatment ever approved by NICE. The approval reflects the exceptional benefit this treatment can offer young babies, potentially allowing them to reach normal childhood developmental milestones. 

Catch up on all our latest news articles
NICE Talks podcast logo

NICE process review: should you take part?

In our monthly podcast we've asked Eric Low, of Eric Low Consulting and former chief executive of Myeloma UK and Jennifer Prescott, programme director in the Centre for Health Technology Evaluation at NICE, why everyone with an interest in NICE should take part in our process review consultation.

Clinical knowledge summaries

We've recently updated the following clinical knowledge summary (CKS) topics:

  • Contraception – emergency. We’ve updated the topic structure and clarified the recommendations in line with the Faculty of Sexual and Reproductive Healthcare guidelines.

  • Contraception – IUS/IUD. We’ve updated the topic structure and clarified the recommendations in line with the Faculty of Sexual and Reproductive Healthcare guidelines.
Our CKS provide primary care practitioners with a readily accessible summary of the evidence base and best practice guidance for over 370 topics. These cover 1,000 clinical presentations or patient scenarios, free to access in the UK.

Into practice

Join our audience insight community

We’re looking for new members from the health and social care sector.  Join over 1,500 healthcare, social care and public health professionals , to help inform and develop our work. You’ll be invited to share your views on topics such as:

  • our guidance and rapid guidance
  • implementing our guidance and views on our support and resources
  • usability of our website and other resources
  • our strategic projects.

Should you decide to join us, you’ll have the flexibility of participating in a way that suits your existing commitments, including:

  • focus groups and workshops
  • in-depth interviews
  • user testing
  • surveys.
Join our audience insight community
Picture montage with the faces of our six new non-executive directors

6 new non-executive directors appointed to our board

Our new non-executive directors will bring an impressive array of expertise in guiding NICE to deliver our objectives and implementation of our new strategic plan.


Generic graphic with the details of the launch strategy event

NICE to launch new 5-year strategy

Join us for the virtual launch of our ambitious 5-year strategy and learn what it means for the health and care sector on Monday 19 April 2021, 11am to 12:15pm.

Hear directly from our leadership team and board about how we plan to make our guidance easier to access and use, and become more dynamic and responsive in our vital work to improve health and care outcomes.

Register to attend strategy launch

Get involved

Have your say: public consultation on our health technology evaluation processes

Our public consultation on proposals for changes to the processes NICE uses to produce its guidance on medicines, medical devices, diagnostics and digital health technologies is open until Thursday 15 April 2021.

Get involved in the consultation

Comment on a consultation

Our current consultations include:

Consultation is a key part of our guidance development process. It enables those with an interest in our guidance to comment at specific stages and feedback into the decision-making process.
See all our open consultations

Join a committee

We’re looking for GPs and nurses to join 5 committees:

See all our committee vacancies

Observe a meeting

Due to the coronavirus pandemic, we're currently holding all our public meetings virtually. You'll need to register in advance to join. 

Upcoming public meeting:

  • Friday 23 April 2021 – Medical technologies advisory committee.
    • Evaluation of GID-MT550 DyeVert for reducing contrast media in coronary and peripheral angiography.
    • Evaluation of GID-MT551 Prontosan for acute and chronic wounds
    Registration closes Tuesday 6 April 2021.
    Agenda and register here
Our advisory committee meetings, technology appraisal appeal hearings and public board meetings are open to the public. Holding them in public supports our commitment to having processes in place that are rigorous, open, and transparent.
See all our public meetings

unsubscribe from this list